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Importance of Line and Length for Mitral Isthmus. Introduction: Mitral isthmus (MI) ablation
is an effective option in patients undergoing ablation for persistent atrial fibrillation (AF). Achieving
bidirectional conduction block across the MI is challenging, and predictors of MI ablation success remain
incompletely understood. We sought to determine the impact of anatomical location of the ablation line on
the efficacy of MI ablation.
Methods and Results: A total of 40 consecutive patients (87% male; 54 ± 10 years) undergoing stepwise
AF ablation were included. MI ablation was performed in sinus rhythm. MI ablation was performed from
the left inferior PV to either the posterior (group 1) or the anterolateral (group 2) mitral annulus depending
on randomization. The length of the MI line (measured with the 3D mapping system) and the amplitude of
the EGMs at 3 positions on the MI were measured in each patient. MI block was achieved in 14/19 (74%)
patients in group 1 and 15/21 (71%) patients in group 2 (P = NS). Total MI radiofrequency time (18 ±
7 min vs. 17 ± 8 min; P = NS) was similar between groups. Patients with incomplete MI block had a longer
MI length (34 ± 6 mm vs. 24 ± 5 mm; P < 0.001), a higher bipolar voltage along the MI (1.75 ± 0.74 mV
vs. 1.05 ± 0.69 mV; P < 0.01), and a longer history of continuous AF (19 ± 17 months vs. 10 ± 10 months;
P < 0.05). In multivariate analysis, decreased length of the MI was an independent predictor of successful
MI block (OR 1.5; 95% CI 1.1–2.1; P < 0.05).
Conclusions: Increased length but not anatomical location of the MI predicts failure to achieve bidirec-
tional MI block during ablation of persistent AF. (J Cardiovasc Electrophysiol, Vol. 26, pp. 629-634, June
2015)
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Introduction
Catheter ablation is an established treatment option for pa-
tients with symptomatic atrial fibrillation (AF). In paroxys-
mal AF (PAF) ablation, pulmonary vein isolation (PVI) is a
well-defined procedural endpoint. In persistent AF (PsAF),
PVI alone results in modest freedom of AF, with medium-
term success rates ranging from 11–46%,1-4 and additional
substrate modification is necessary to increase the success
rate. Previous studies have shown that linear ablation at the
mitral isthmus (MI) in addition to PVI increases the rate of
sinus rhythm (SR) maintenance in persistent AF patients.5-7
Hypotheses concerning the additional benefit of the
MI ablation line during AF ablation are the following:
(1) the elimination anatomic or functional reentries (ro-
tors/macroreentrant AT), (2) elimination ofarrhythmogenic
doi: 10.1111/jce.12667
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triggers (i.e., ligament of Marshall), and (3) impact on auto-
nomic innervation.
Performing the MI line, however, is difficult and acute
bidirectional block is achieved in a limited amount of
patients.5,6,8,9 Increased success is often associated with
increased risk of complications from higher ablation power
and higher risk of steam pop, perforation, and tamponade.10
Furthermore, incomplete block across left atrial (LA) abla-
tion lines can be responsible for proarrhythmia and atrial
tachycardia (AT) recurrence.6,11,12 The 2012 HRS/EHRA/
ECAS AF ablation guidelines state that if additional linear
lesions are applied in persistent AF (PsAF) ablation, line
completeness should be assessed.13 While the importance
of the MI line has been demonstrated, the predictors of MI
ablation success and preferential anatomical location of the
MI line have not been assessed.
The aim of this prospective randomized study therefore
was to (1) determine the impact of the exact anatomical
location of the ablation line on efficacy of MI ablation in




The study population comprised 40 consecutive patients
undergoing their first catheter ablation for symptomatic and
drug-refractory persistent AF between November 2010 and
February 2012 at Hopital Cardiologique du Haut-Leveque,
Bordeaux-Pessac. The research protocol was approved by the
local ethics committee and all patients provided written in-
formed consent. Persistent AF was defined as AF sustaining
beyond 7 days, or lasting <7 days but necessitating pharma-
cological or electrical cardioversion; longstanding persistent
AF was defined as continuous AF of>1-year duration.13 All
patients gave written informed consent according to the in-
stitutional guidelines of the University of Bordeaux Health
System (who provided ethical approval for the study). Pa-
tients were randomized in 1:1 fashion to either posterior or
anterolateral isthmus lines.
Electrophysiological Study
Antiarrhythmic medications were discontinued 5 half-
lives prior to ablation with the exception of amiodarone.
All patients were on coumadin oral anticoagulantion and
achieved a target INR of 2–3 for at least 1 month prior to
ablation. Transesophageal echocardiography was performed
within 5 days of the procedure to exclude atrial thrombus.
Oral anticoagulation was stopped 48 hours before the proce-
dure and resumed on the day following the ablation.
Femoral venous access was established under local anes-
thesia and conscious sedation. A steerable quadripolar or
decapolar catheter (5 mm electrode spacing, Xtrem, ELA
Medical, Montrouge, France) was placed within the CS. Fol-
lowing transseptal access, an intravenous bolus of heparin
(0.5 mg/kg of body weight) was administered and repeated
when the activated clotting time was <250 seconds.
Surface electrocardiograms (ECGs) and intracardiac elec-
trograms (EGMs) were continuously monitored at a sweep
speed of 100 mm/s and recorded (Labsystem Pro, Bard,
Tewksbury, MA, USA) and were filtered from 0.05 to 100 Hz
and 30 to 500 Hz, respectively.
Mitral Isthmus Line Characteristics and Ablation
A 3D anatomical map of the left atrium was made at
the outset of the case using Carto 3TM (Biosense Webster,
Diamond Bar, CA, USA) with careful attention paid to iden-
tification of the PVs as well as the mitral annulus (Fig. 1). The
area subtended by either MI line was segmented on the map
so that no ablation would be directed to this area during pul-
monary vein isolation and ablation of complex fractionated
electrograms (CFAEs).
Following pulmonary vein isolation, CFAE ablation and
linear lesion at the roof and the cavotricuspid isthmus (CTI)
were performed. If the patient was still in AF or tachycardia,
DC cardioversion was performed to achieve sinus rhythm.
MI measurements and linear ablation were always carried
out during sinus rhythm. The MI line was performed during
CS pacing (as close as possible to the MI line, posterior
side) in all cases. The length of the MI line was measured
with the 3D mapping system. The maximal amplitude of
the bipolar EGMs at 3 different positions on the MI was
also measured in each patient in SR before the start of MI
ablation.
Patients were randomized in a 1:1 fashion to 1 of 2 MI
ablation arms (Figs. 1 and 2).
(1) Posterior MI ablation (group 1): The linear lesion was
performed from the posterior mitral annulus to the left
inferior PV (posterior side) by drawing a vertical line.
Briefly, the ablation catheter (Navistar R© Thermocool R©
3.5 mm; Biosense Webster) was introduced through a
long sheath (SL0, St. Jude Medical, Minneapolis, MN,
USA) to aid stability during ablation. Using a clock-
face analogy, ablation commenced at 6 o’clock (left
anterior oblique [LAO] view) on the ventricular edge
of the mitral annulus. The catheter was dragged grad-
ually back into the sheath to extend the lesion along
the isthmus in a linear fashion up to the left infe-
rior PV ostium. Every effort was a made to perform
a truly linear ablation and to keep the point-by-point ab-
lation line as narrow as possible not to interfere with
the anterolateral MI area whose ablation was tested in
group 2.
(2) Anterolateral MI ablation (group 2): The linear lesion
was performed from the anterolateral mitral annulus to
the left inferior PV (anterior side) by drawing a horizon-
tal line. In this case, ablation commenced at 3 o’clock
(LAO view) on the ventricular edge of the lateral mitral
annulus. The catheter was dragged gradually back into
the sheath to extend the lesion along the isthmus in a
linear fashion up to the anterior part of the left inferior
PV ostium.
In both groups, after initial ablation, endocardial and epi-
cardial mapping was performed to identify and ablate any
gaps. Endocardial ablation was performed with a flow rate of
12–60 mL/min, and maximal temperature of 45 °C (usually
below 42 °C) with power set at 35 W. Epicardial ablation was
performed in the coronary sinus (CS) with power limited to
25 W. The endpoint of ablation was achievement of bidirec-
tional MI conduction block demonstrated using previously
described techniques and criteria.14,15
MI ablation was stopped after a maximum of 30 minutes
of RF application, and this was considered as failure.
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Figure 1. LAO and RAO views of the
heart displaying a decapolar catheter in
the coronary sinus and a Lasso catheter
in the left inferior pulmonary vein. The
dashed line illustrates the posteror mitral
isthmus line, whereas the full line displays
the anterolateral mitral isthmus line.
Figure 2. Electroanatomic maps and ab-
lation lesions in patients with a poste-
rior MI line (group 1) and an antero-
lateral MI line (group 2). The relevant
lesion sets are highlighted with a black
ellipse (posterior MI line) and a white
ellipse (anterior line). A and B: A mod-
ified posterior view of the left atrium:
C and D: A modified left lateral view.
For a high quality, full color version of




Continuous variables were presented as mean ± SD, or
median (and interquartile range [IQR]), depending on nor-
mality of distribution. Categorical variables are presented
as percentages (%) and counts. Continuous variables were
compared with Student t-test or the Wilcoxon rank-sum test
(nonnormally distributed data), and frequencies with chi-
square analysis or Fisher’s exact test for small numbers,
as appropriate. Univariate logistic regression was performed
to estimate the magnitude of risk associated with potential
risk factors for MI block. Where appropriate, the receiver–
operator characteristic (ROC) curve was determined to eval-
uate the performance of the best independent predictor of MI
block. The optimal cut-off point was chosen as the combi-
nation with the highest sensitivity and specificity (Youden
Index).
For the stepwise logistic regression analysis, the continu-
ous variables were appropriately transformed where required
to binary variables based on the ROC curve analysis. A
multivariable Cox proportional hazard model was used to
investigate the association between baseline characteristics
and procedural data (inclusion of all parameters showing a
P < 0.05 at univariate analysis) and MI block. For each
variable, odds ratio (OR), 95% confidence interval (CI), and
Wald test P values of the final model were displayed. All
tests of significance were 2-tailed, and a P value of less than
0.05 was considered to indicate statistical significance. All
analyses were performed with SPSS 18.0.
Results
Clinical Characteristics
Patients’ characteristics are shown in Table 1. Of the 40 pa-
tients enrolled in the study, 19 patients were randomized
to group 1 and 21 patients were randomized to group 2.
There was no significant difference in the age, gender, type
of AF, presence of structural heart disease, duration of un-
interrupted persistent AF, use of antiarrhythmic drugs prior
to ablation, and echocardiographic left heart dimensions be-
tween the 2 arms.
Ablation
MI block was achieved in 14/19 patients (74%) in group 1
and in 15/21 patients (71%) in group 2 (P = NS). Total MI
radiofrequency time (18 ± 7 min vs. 17 ± 8 min; P = NS)
and ablation rate in the CS (81% vs. 77%; P = NS) were
similar between groups (Table 2). No complication occurred
during the procedures.
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TABLE 1
Baseline Characteristics (n = 40 patients)
Female gender 5 (13%)
Age (years) 54 ± 9
History of AF (months) 51 ± 36
Continuous AF duration (months) 13 ± 9
Long standing persistent AF 17 (43%)
Obesity (BMI > 30) 14 (36%)
Amiodarone at time of procedure 13 (33%)
Left atrial diameter (mm) 46 ± 5
Left ventricular ejection fraction (%) 55 ± 14
Hypertension 15 (38%)
Structural heart disease 15 (38%)
CHADS2 score 2 9 (23%)
Values are given as n (%) or as mean ± SD, unless otherwise noted. AF =
atrial fibrillation; BMI = body mass index.
TABLE 2
Univariate Analysis Comparing MI Ablation Groups
Posterior Anterolateral
MI Line MI Line
Variable (n = 19) (n = 21) P Value
Bidirectional MI block 14 (74%) 15 (71%) 0.87
Length of MI line (mm) 27 ± 7 28 ± 8 0.73
Mean MI voltage (mV) 1.16 ± 0.74 1.33 ± 0.80 0.50
Fluoroscopy time (minutes) 14 ± 7 15 ± 9 0.90
Total RF time (minutes) 23 ± 8 25 ± 11 0.59
RF time in CS (minutes) 4 ± 3 4 ± 5 0.93
RF in CS 16 (84%) 18 (86%) 0.89
Delay across MI line (milliseconds) 131 ± 40 139 ± 36 0.46
MI = mitral isthmus; RF = radiofrequency; CS = coronary sinus.
TABLE 3
Univariate Analysis Comparing the Successful MI Ablation Group with
the MI Ablation Failure Group
Success Failure
Variable (n = 29) (n = 11) P Value
Age (years) 52 ± 7 55 ± 10 0.35
History of AF (months) 51 ± 43 52 ± 39 0.94
Cont. AF duration (months) 10 ± 10 19 ± 17 0.04*
Obesity (BMI >30) 7 (25%) 7 (64%) 0.03*
Amiodarone at time of procedure 11 (37%) 2 (18%) 0.29
LA diameter (mm) 45 ± 4 48 ± 6 0.07
LV ejection fraction (%) 56 ± 15 54 ± 12 0.75
Hypertension 11 (37%) 4 (36%) 0.93
Structural heart disease 10 (38%) 5 (45%) 0.52
Length of MI line (mm) 24 ± 5 34 ± 6 <0.001*
Mean MI voltage (mV) 1.05 ± 0.69 1.76 ± 0.75 <0.01*
RF in CS 23 (79%) 11 (100%) 0.10
Abbreviations as for Tables 1 and 2.
MI Line Characteristics
Overall, patients with incomplete MI block had a longer
MI line length (34 ± 6 mm vs. 24 ± 5 mm; P < 0.001),
a higher mean bipolar voltage along the MI line (1.75 ±
0.74 mV vs. 1.05 ± 0.69 mV; P < 0.01), a longer history
of continuous AF (19 ± 17 months vs. 10 ± 10 months;
P < 0.05), and a higher rate of obesity (75% vs. 16%;
P < 0.05) (Table 3).
In multivariate analysis, a decreased length of the MI line
was an independent risk factor for success in blocking the
MI (OR 1.5; 95% CI 1.1–2.1; P < 0.05) after adjustment for
mean MI voltage<1.17 mV, absence of obesity, and absence
of longstanding persistent AF.
Interestingly, we found a moderate correlation between
the length of the mitral line and the ablation time (correlation
coefficient = 0.575; P < 0.001).
Discussion
This study highlights the importance of the MI length for
achieving bidirectional MI electrical block. It also confirms
the difficulty in achieving conduction block across the MI line
that still represents the most difficult step (when necessary)
during AF ablation.
Difficulty in MI Abation
MI line still represents the most difficult step in AF ab-
lation. Reported success rates range from 65% to 92%.5,6,8,9
Increased success rates often require higher power for abla-
tion and this is associated with an increased risk of tampon-
ade. The MI is a corridor of uncertainty and the technical
challenge when performing an MI line can be explained by
(1) the wall thickness of the MI, (2) the presence of numerous
recesses and cavities along the MI,16 (3) the presence of epi-
cardial muscular connections necessitating ablation within
the CS in the majority of patients,5 (4) the anatomical lo-
cation with the presence of the LA appendage, and (5) the
technical challenge of catheter stability as compared to the
CTI line for instance.
Postmortem anatomical and in vivo studies have shown
that the atrial myocardium from the left inferior pulmonary
vein to the lateral aspect of the mitral valve has a wall thick-
ness up to 10 mm.17
Our study confirms the technical challenge of MI abla-
tion, with a global success rate of only 73%. We have to
notice that power has been restricted to less than 35 Watts
with the intention to avoid serious complication, which has
been the case. For the purpose of the study, we have also
limited the duration of RF application for the MI line to less
than 30 minutes, even if conduction delay had significantly
increased.
This difficulty in achieving conduction block at the MI
line raised the question of the timing and overall necessity to
perform this linear lesion. The global aim of linear lesions
is to reproduce the surgical MAZE procedure, based on the
concept of macroreentrant loop and wandering wavelets par-
ticipating in the AF process. Several studies have described
the additional benefit of the LMI line particularly for persis-
tent AF,6,16 but at the expense of more complications. Im-
portantly, even when not performed during AF, MI line has
frequently to be done after AF termination for subsequent
peri-mitral flutter.6
Localization of the MI Line
We investigated the potential benefit of MI localization
in the success rate of this technique. Theoretically, a more
posterior approach allows for avoiding the area of the LA ap-
pendage, which can be a source of perforation and is probably
the thickest part of the MI area. However, posterior applica-
tion always represents a potential risk for atrio-esophageal
fistula. Our study did not evidence any difference in per-
formance concerning the localization. During multivariate
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analysis, only the length of the MI line was important for
procedural success.
Interestingly, a higher bipolar voltage along the MI line
was not associated with more failure of bidirectional block
in multivariate analysis. During CTI ablation, ablation tar-
geting maximum voltage has been shown to reduce RF
duration,18 suggesting the presence of discrete muscle bun-
dles separated by connective tissue.19 This seems not to
be the case for the MI where most electrograms were rel-
atively ample and with no difference in the reported success
rate.
Interestingly, Pak et al.20 studied an alternative approach
to the classic left anterolateral or posterior MI, namely a line
on the LA anterior wall. The length of this anterior line during
ablation was longer (37.9 ± 3.4 mm vs. 26.6 ± 3.2 mm, P<
0.0001), but achievement of bidirectional block was higher
(68% vs. 32%, P < 0.0001) than with a left lateral isthmus
ablation. In our own experience, we also found the left lateral
isthmus to be shorter and the achievement of bidirectional
block less challenging to achieve than when ablating the left
anterior line between the anterior MI and the roof line or the
right superior pulmonary vein.
Clinical Implications
This study would suggest that there might be utility in
measuring the shortest way from the mitral annulus to the left
inferior PV. This could potentially increase the success rate
of MI line ablation, when this line is necessary either during
AF of for the occurrence of a perimitral flutter. However,
other parameters can be taken into account: the stability of
the catheter during ablation, access to the distal CS as this is
necessary in most of the cases, the presence of the esophagus
near the left veins or a close position of the LA appendage
as compared to the left inferior PV.
Limitations
This is a single-center study with limited patient numbers.
No CT/MR imaging and image integration was performed,
which may have increased the procedural success. Anatomi-
cal differences of the MI in cases that were successful versus
those that were unsuccessful were also not evaluated. How-
ever, all of the procedures have been performed with a 3D
electro-anatomical system. At the time of our study, we did
not routinely use force sensing catheters and therefore we
can provide no information on the force integral necessary
to achieve MI block.
Finally, no steerable sheath was used, which has been
demonstrated to increase the success rate.
Conclusions
In patients undergoing persistent AF ablation using the
stepwise approach, decreased length but not anatomical lo-
cation of the MI line as assessed with a 3D mapping system
predicts success in achieving bidirectional mitral isthmus
block.
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